Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuraSeed BCI is a neurotechnology company dedicated to developing high-bandwidth brain-computer interfaces (BCIs) designed to restore autonomy to individuals with severe physical disabilities. The company focuses on creating advanced neural implants and decoding algorithms that translate brain activity into digital commands, enabling communication and control of external devices. By leveraging innovations in micro-electrode arrays and signal processing, NeuraSeed BCI aims to bridge the gap between human cognition and digital technology. Their primary mission is to address unmet needs in patients suffering from paralysis, spinal cord injuries, and neurodegenerative diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuraSeed BCI.